Literature DB >> 16242823

Neuroimaging studies of obsessive-compulsive disorder in adults and children.

Laura Friedlander1, Mary Desrocher.   

Abstract

Obsessive-compulsive disorder (OCD) is a severe, highly prevalent and chronically disabling disorder that usually emerges during childhood or adolescence. Neuroimaging studies play an important role in advancing our understanding of the pathophysiology of OCD and in developing neurocircuitry models of this psychiatric illness. This paper provided an updated, comprehensive review and analysis of the relevant literature on baseline functional and structural neuroimaging studies of OCD in both paediatric and adult patients. The neuroanatomical findings were presented in the context of two models: executive dysfunction, which implicates the dorsolateral prefrontal cortex, caudate nucleus, thalamus, and striatum; and modulatory control, which implicates the orbitofrontal and medial prefrontal cortex and the cingulate gyrus. Neuroanatomical findings were not consistent across all studies, and limitations were examined. Recommendations for future research directions and the implications of the results for improved treatment were explored.

Entities:  

Mesh:

Year:  2005        PMID: 16242823     DOI: 10.1016/j.cpr.2005.06.010

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  42 in total

1.  Structural changes in the gray matter of unmedicated patients with obsessive-compulsive disorder: a voxel-based morphometric study.

Authors:  Ling Tan; Qing Fan; Chao You; Jijun Wang; Zhao Dong; Xuemei Wang; Kemin Chen; Zeping Xiao; Kaida Jiang
Journal:  Neurosci Bull       Date:  2013-08-28       Impact factor: 5.203

2.  Altered source memory retrieval is associated with pathological doubt in obsessive-compulsive disorder.

Authors:  Christy A Olson; Lisa R Hale; Nancy Hamilton; Joshua N Powell; Laura E Martin; Cary R Savage
Journal:  Behav Brain Res       Date:  2015-08-24       Impact factor: 3.332

Review 3.  Divergent plasticity of prefrontal cortex networks.

Authors:  Bita Moghaddam; Houman Homayoun
Journal:  Neuropsychopharmacology       Date:  2007-10-03       Impact factor: 7.853

Review 4.  Structural and functional neuroimaging in Klinefelter (47,XXY) syndrome: a review of the literature and preliminary results from a functional magnetic resonance imaging study of language.

Authors:  Kyle Steinman; Judith Ross; Song Lai; Allan Reiss; Fumiko Hoeft
Journal:  Dev Disabil Res Rev       Date:  2009

5.  Architectonic distribution of the serotonin transporter within the orbitofrontal cortex of the vervet monkey.

Authors:  B M Way; G Laćan; L A Fairbanks; W P Melega
Journal:  Neuroscience       Date:  2007-07-17       Impact factor: 3.590

6.  Clorgyline-induced modification of behavioral sensitization to quinpirole: effects on local cerebral glucose utilization.

Authors:  Toni L Richards; Thomas L Pazdernik; Beth Levant
Journal:  Brain Res       Date:  2007-05-31       Impact factor: 3.252

7.  Quantitative morphology of the corpus callosum in obsessive-compulsive disorder.

Authors:  Katherine C Lopez; Francois Lalonde; Anand Mattai; Benjamin Wade; Liv Clasen; Judith Rapoport; Jay N Giedd
Journal:  Psychiatry Res       Date:  2013-03-01       Impact factor: 3.222

8.  Brain activation during cognitive planning in twins discordant or concordant for obsessive-compulsive symptoms.

Authors:  Anouk den Braber; Dennis van 't Ent; Danielle C Cath; Judith Wagner; Dorret I Boomsma; Eco J C de Geus
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

9.  The role of the striatum in compulsive behavior in intact and orbitofrontal-cortex-lesioned rats: possible involvement of the serotonergic system.

Authors:  Eduardo A Schilman; Oded Klavir; Christine Winter; Reinhard Sohr; Daphna Joel
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

Review 10.  The neurocircuitry of fear, stress, and anxiety disorders.

Authors:  Lisa M Shin; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.